Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Purchase | 2024-05-31 4:56 pm | Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director | 57,208 | $8.74 | $499,998 | 743,231 (Indirect Direct) | View |
| 2024-02-16 Purchase | 2024-02-16 2:37 pm | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Mgmt HIF L.P. Deerfield Mgmt IV L.P. Deerfield Mgmt L.P. Deerfield Private Design Fund III L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Private Design Fund IV L.P. DEERFIELD PARTNERS L.P. * Director by Deputization Director 10% Owner | 4,290,617 | $8.74 | $37,499,993 | 8,929,179 (Indirect) | View |
| 2024-02-14 Purchase | 2024-02-15 4:21 pm | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 2,000 | $11 | $22,000 | 2,000 (Direct) | View |
| 2023-12-07 Purchase | 2023-12-08 4:08 pm | Larimar Therapeutics Inc. | LRMR | Shankar Gopi Chief Development Officer | 5,000 | $3.7323 | $18,662 | 5,000 (Direct) | View |
| 2023-05-17 Purchase | 2023-05-18 2:13 pm | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 5,000 | $3.7263 | $18,632 | 112,746 (Direct) | View |
| 2023-05-17 Purchase | 2023-05-18 2:13 pm | Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO | 5,000 | $3.705 | $18,525 | 266,829 (Direct) | View |
| 2023-05-17 Purchase | 2023-05-18 2:12 pm | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 2,750 | $3.73 | $10,258 | 2,750 (Direct) | View |
| 2022-09-16 Purchase | 2022-09-20 8:31 pm | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Mgmt HIF L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund III L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Private Design Fund IV L.P. * Director by Deputization Director 10% Owner | 11,111,108 | $3.15 | $34,999,990 | 2,777,777 (Indirect) | View |
| 2022-09-16 Purchase | 2022-09-20 06:54 am | Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director | 317,460 | $3.15 | $999,999 | 667,023 (Indirect Direct) | View |
| 2022-09-16 Purchase | 2022-09-19 07:00 am | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 31,746 | $3.15 | $100,000 | 31,746 (Direct) | View |
| 2022-09-16 Purchase | 2022-09-19 07:00 am | Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO | 31,746 | $3.15 | $100,000 | 56,829 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-29 Option Award | 2024-06-03 6:31 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
| 2024-05-29 Option Award | 2024-05-31 4:58 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:57 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:57 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | SHERMAN JEFFREY W Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:57 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:56 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director | 19,000 | $0 | 743,231 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:33 pm | N/A 2034-01-17 | Larimar Therapeutics Inc. | LRMR | Shankar Gopi Chief Development Officer | 157,500 | $0 | 162,500 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:32 pm | N/A 2034-01-17 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 218,750 | $0 | 331,496 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:31 pm | N/A 2034-01-17 | Larimar Therapeutics Inc. | LRMR | Clayton Russell Chief Medical Officer | 157,500 | $0 | 157,500 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:31 pm | N/A 2034-01-17 | Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO | 462,875 | $0 | 729,704 (Direct) | View |
| 2023-10-03 Option Award | 2023-10-05 4:33 pm | N/A 2033-10-03 | Larimar Therapeutics Inc. | LRMR | SHERMAN JEFFREY W Director | 16,600 | $0 | 16,600 (Direct) | View |
| 2023-07-17 Option Award | 2023-07-18 4:15 pm | N/A 2033-07-17 | Larimar Therapeutics Inc. | LRMR | Clayton Russell Chief Medical Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 6:31 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 8,300 | $0 | 8,300 (Indirect) | View |
| 2023-05-09 Option Award | 2023-05-11 4:29 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:29 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:29 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:28 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:06 pm | N/A 2033-02-07 | Larimar Therapeutics Inc. | LRMR | Shankar Gopi Chief Development Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:16 pm | N/A 2033-01-31 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 196,000 | $0 | 227,746 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:15 pm | N/A 2033-01-31 | Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO | 530,000 | $0 | 586,829 (Direct) | View |
Ownership | 2022-09-20 8:30 pm | N/A N/A | Larimar Therapeutics Inc. | LRMR | DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Dir. by Deputization/10% Group Director 10% Owner | 0 | $0 | 2,777,777 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:28 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | BEN-MAIMON CAROLE President and CEO | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:28 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Celano Michael Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:28 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:27 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Barrett Peter Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:27 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Hamilton Thomas Edward Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:27 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | LEFF JONATHAN S Director | 8,300 | $0 | 8,300 (Direct) | View |